Or you can go straight to uniprot. Every available PDB + alphafold model
is linked to the uniprot entry.
On Fri, Jul 29, 2022 at 4:46 PM Robbie Joosten
wrote:
> Hi Paul,
>
> From the PDB file get the Uniprot primary accession code (see DBREF) and
> use this to get the Alphafold model using 3D-b
Hi All,
We have an exciting job opportunity in structural biology! *Please apply
at:*
https://us.eisai.com/careers-at-eisai/job-detail?searchParam=H3%20Biomedicine&id=JOB_POSTING-3-9560
H3 is an oncology-focused company leveraging the latest cancer genomics
data to inform drug discovery. The qua
I hope this doesn't confuse the discussion, but my understanding was "UNK"
stood for "unknown" residue and this will cause errors. UNK naming
convention is the default output of Schrodinger when generating ligand PDB
files. Coot will display the PDB containing "UNK" as a residue, but if you
try t
Hi Frank, I thought we were working quickly, but we only just got all of
your structures uploaded in our Proasis system today and can only now begin
analysis and design ideas. I don't know if we will have much of anything
by your deadline. Will there be additional design rounds? Thanks again
for
Hi Frank,
Congratulations on this impressive and valuable contribution to the efforts
against covid and I applaud your transparency and crowdsourcing efforts on
this global problem. Your team is really an inspiration to us all. We are
working to get all your structures uploaded for our med chemis
Dear CCP4 users,
This is off topic and directed more towards industry users. I would really
appreciate any help recommending an in house "PDB" data base for storing
proprietary structures. My impression is the big pharma make their own
customized data base and a lot of biotechs just dump their co
Dear All, we have an opening for a permanent hire in my group so please
send me your resumes if interested and/or please forward to anyone you know
who may be looking for a terrific opportunity in biotech.
Thanks!
Nick
*Scientist – Structural Biology*
*Contact: nicholas_lar...@h3biomedicine.co
Dear Colleagues,
We recently acquired HDX data on a target, which basically gives us %change
per residue over the entire primary sequence. Is there a simple way to
reassign the B-factor column of my PDB with those %change numbers so I can
then easily color the molecular surface? I hope the questi
You use the Dali server for that :)
http://ekhidna.biocenter.helsinki.fi/dali_server
On Mon, Sep 18, 2017 at 12:21 PM, Chetan Arya
wrote:
> Hi all,
> I want to know if there is any server/software which does the PDB based
> (structure based) fold recognition. All I got for fold prediction are
Did anyone suggest adding any known ligand? If your protein happens to
bind some compound/peptide/DNA/RNA/whatever, including that other partner
could dramatically change it's solution properties and be an easy fix for
your handling/formulation issues.
Good luck!
On Fri, Jul 14, 2017 at 6:33 AM,
In theory, what you say is quite sensible. But there is one interesting
counter example I am aware of.The fragment tool compound that
eventually gave rise to the clinical compound indeglitazar (
http://www.pnas.org/content/106/1/262.full.pdf) gives a negative shift by
DSF (in our hands):
[imag
One thing that sometimes helps me in this situation is reprocess and refine
in lower symmetry like P21. It could be you have pseudosymmetry and need
to model more molecules in the AU to better reflect your data. Sometimes
this can help. If that doesn't work, then you may have to stick with your
Dear colleagues,
We have a target where people have measured Kd's for ligands using
radioligand binding assays. Several publications report Kd's of single
digit nanomolar and we are able to reproduce that data using this assay
format. When we try to do the same measurement using ITC, we generate
I agree with Herman about shorter soak. In addition, if your crystals can
tolerate any change in pH, you can slow your reaction down by tweaking this
parameter. Another thing you should think about is the kinetics of the
reaction, especially the rate limiting step. If the rate limiting step is
p
These suggestions are all possible, but why not simply lyophilize it into a
tared tube and weigh it out?
On Mon, Feb 6, 2017 at 12:28 PM, Alex Lee wrote:
> Thank you all for your suggestions!
>
> On Mon, Feb 6, 2017 at 5:53 AM, Artem Evdokimov > wrote:
>
>> Hi,
>>
>> In addition to HABA dye ass
Dear All,
I'm sorry if this is off topic, but it might be of interest to general
audience. I want to get one of our crystal structures etched in glass.
Can anyone help recommend a company that can provide this service? BioEtch
had come highly recommended to me, but unfortunately their website
cur
Dear All,
I have CCP4 6.5.0 installed on my laptop PC. Everything runs fine, to my
knowledge, except JLigand. When I click this program from the program
list, absolutely nothing happens. No error message, nothing. It doesn't
launch. Do I need to reinstall cpp4 or is JLigand a separate installa
Screen for heavy atoms with native gel. Run protein with variety of heavy
atoms. If you see a discreet shift in the native gel, then you will get
derivative. If you don't see a shift, don't bother soaking. It's worked
for me every time. Also, ammonium sulfate will mess up your heavy atoms,
so
Dear All,
I frequently use the Coot feature "Fetch PDB and MAP using EDS..." with
great success when peer reviewing literature reports. However, when I try
this for the recent KRAS structures deposited by Kevan Shokat and Jim Wells
(Nature 2013), the Coot generated maps are garbage, although the r
I don't think storage matters. I doubt Hampton stores their PEG stock
solutions at -80 before they ship out to customers.
I've solved tons of structures leaving my PEGS and PEG screens at RT in the
light.
Nick
On Mon, Jul 14, 2014 at 12:32 PM, Chris Fage wrote:
> Hi Jerome,
>
> -I have heard
Looks like you're on the twofold axis, which will make interpretation
challenging. Anything you put in may end up being too close to itself in
the neighboring AU. What happens if you put in a water and display the
symmetry?
On Mon, Jun 23, 2014 at 8:17 AM, Shanti Pal Gangwar
wrote:
> Dear All
H3 Biomedicine seeks to recruit an outstanding postdoctoral candidate in
structural biology. Our major area of research is RNA splicing in cancer.
We have developed tool molecules targeting aberrant splicing in SF3B1
mutant cancers. Our goal is to understand the structural basis for aberrant
splic
22 matches
Mail list logo